Featured Articles
Trending Articles
FDA Grants Accelerated Approval to Bizengri for Treating NRG1+ Pancreatic Cancer and NSCLC
FDA & EMA | 5 December 2024
Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL
Clinical Trials | 9 December 2024
Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia
Clinical Trials | 8 December 2024
AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors
AI | 6 December 2024
Promising Sac-TMT Receives FDA Breakthrough Therapy Designation for Lung Cancer
FDA & EMA | 7 December 2024
Durvalumab Granted FDA Priority Review for Muscle-Invasive Bladder Cancer Patients
FDA & EMA | 7 December 2024
FDA Approves Durvalumab as the First and Only Immunotherapy for LSSC Lung Cancer
FDA & EMA | 5 December 2024
AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer
AI | 29 November 2024
The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia
FDA & EMA | 27 November 2024
Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation
Pharma | 28 November 2024
SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer
Clinical Trials | 26 November 2024
FDA Greenlights Revumenib for Relapsed Leukemia Treatment
ONCOLife | 23 November 2024
FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer
ONCOLife | 22 November 2024
How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment
ONCOLife | 21 November 2024
UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets
ONCOLife
19 November 2024
FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy
ONCOLife
9 November 2024
IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer
Clinical Trials
7 November 2024
Role of CGP Testing in the Management of Cancer Treatment and Personalized Care
ONCOLife
4 November 2024
Transforming Melanoma Treatment with DNA Plasmid Vaccine
ONCOLife
28 October 2024
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
Webinar
31 October 2024
FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic
Biotech
21 October 2024
AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma
FDA & EMA
17 October 2024
FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer
FDA & EMA
19 October 2024
Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers
Pharma
18 October 2024